Sun Yat-sen University Cancer Center — Guangzhou
The world's leading centre for nasopharyngeal cancer — southern China's premier oncology institution
Founded
1964
Beds
1,488
Location
Guangzhou
About SYSUCC
Sun Yat-sen University Cancer Center (SYSUCC) is the largest integrated cancer centre in southern China, and the world's highest-volume institution for nasopharyngeal carcinoma (NPC) — a cancer significantly more common in southern Chinese and Southeast Asian populations than in Europe. Founded in 1964, SYSUCC has been a WHO Collaborating Centre for Cancer Research since 1980 and is a member of the Union for International Cancer Control (UICC). It provides comprehensive oncology care across surgery, radiation, chemotherapy, immunotherapy, and clinical trials.
Why International Patients Choose SYSUCC
- ✓World's highest-volume and most published institution for nasopharyngeal carcinoma (NPC) — the global reference centre for this diagnosis
- ✓Largest integrated cancer centre in southern China — 42 operating theatres, 4 da Vinci robotic surgery systems, premier radiation oncology suite
- ✓WHO Collaborating Centre for Cancer Research since 1980 — international research partnerships with European and North American cancer institutions
- ✓Dedicated international patient services with English-language VIP wards, private rooms, and medical tourism support
- ✓Active clinical trial programme in immunotherapy and targeted therapy — patients may access protocols not yet approved in European markets
Specialties
Explore related treatment guides:
Accreditations & Standards
Grade 3A is China's highest hospital classification, awarded to institutions meeting the most rigorous standards in clinical quality, staffing, infrastructure, and patient safety. JCI accreditation adds an internationally recognised layer of certification accepted by most European insurers.
Getting There
Frequently Asked Questions
What types of cancer does SYSUCC specialise in?
SYSUCC is the world's highest-volume and most published institution for nasopharyngeal carcinoma (NPC) — a cancer disproportionately common in southern Chinese and Southeast Asian populations. It also has top-ranked programmes for gastrointestinal cancers (gastric, colorectal, oesophageal), lung cancer, breast cancer, and lymphoma. All major oncology modalities — surgery, radiation, chemotherapy, immunotherapy, and targeted therapy — are available within one centre.
Why do international patients travel to SYSUCC from Europe?
The primary reasons are specialist access and cost. For NPC specifically, SYSUCC's expertise is unmatched anywhere in the world — European oncology centres see very few NPC cases per year, while SYSUCC treats thousands. For other cancers, SYSUCC offers immunotherapy and targeted therapy protocols not yet approved in some European countries, at costs typically 50–70% lower than equivalent private European oncology care.
Can I get a second opinion from SYSUCC without travelling to Guangzhou?
Yes. SYSUCC's international team can review pathology reports, imaging, and treatment summaries remotely and provide a written oncology assessment. This is the typical first step for international patients considering treatment. Our coordinators can facilitate the document transfer and translation.
Is Guangzhou accessible from Europe?
Guangzhou Baiyun Airport (CAN) has direct connections to major Asian hubs including Hong Kong, Singapore, Bangkok, and Dubai. Most European patients connect through one of these hubs with a total journey of 14–18 hours. Hong Kong International Airport is 2.5 hours away by direct bus, providing an additional gateway for patients arriving via British Airways, Virgin Atlantic, or Cathay Pacific.
Get a Free Treatment Assessment
Submit your case details and receive a personalised plan within 24 hours — including hospital recommendation, cost estimate, and next steps.